English

Zenas BioPharma Announces Pricing of Upsized Initial Public Offering

WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized

ABOUT us
Welcome to Lebanon News Gazette, your window into the captivating world of Lebanese news and beyond. We are here to deliver timely, accurate, and captivating coverage that keeps you informed and engaged.